Dr Paul Cornes, Oncologist at Comparative Outcomes Group
Comparative Outcomes Group Logo

Dr Paul Cornes

Comparative Outcomes Group

Check out the incredible speaker line-up to see who will be joining Paul.

Download The Latest Agenda
Biosimilars Commercialisation Summit Agenda 2019

Biosimilars Commercialisation Summit Agenda 2019

View Content

Conference Day One

Wednesday, February 5th, 2020

9:20 AM Opening Keynote: A Global View of the Biosimilars Market

  •  Discuss the regionally variable challenges and opportunities that exist across the global biosimilars market  
  • Consider recent and historical trends with a view to explore the future of biosimilars on a global scale
  • Join your colleagues in an open forum for discussion on how you can help drive the industry for mutual benefit

10:10 AM Panel Discussion: Exploring the Sensitivity and Complexity of the North American Biosimilars Market

  • Overcome the current battle to combat misinformation surrounding biosimilars in the US, and the essential methods to boost stakeholder confidence, in the face of immense competition from biologics
  • Discuss the current regulatory landscape with respect to the FDA Biosimilar Action Plan and the newly published regulatory framework  regarding  the use of  real world evidence and real world data
  • Explore the game-changing concept of the ‘Purple Book’ for pharmacists, asking “Does this make either medical or commercial logic?”

Conference Day Two

Thursday, March 5th, 2020

4:10 PM Fire-Side Chat: Objection Handling Q&A

  • Confront trials by engaging with a physician to explore how manufacturers and regulators hope to maintain the trust of the public in a relatively novel class of medicines, faced with such potential for future variability, mistrust and misinformation
  • Explore how the risks of  extrapolation of indications can be minimised and the significance of this practice for the biosimilar industry
  • Bring your own challenges to the forefront of the industry and discuss how to tackle prescriber objections